Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00980148 · ClinicalTrials.gov registry record · Phase 3
Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities
A Phase 3 study of Chlamydial Infection, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 3
- Development phase
- 567
- Enrollment target
- 2
- Study locations
NCT00980148 is a Phase 3 study of Chlamydial Infection that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 567 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT00980148, a Phase 3 study of Chlamydial Infection, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 567 participants
- Enrollment target
- 2
- Study locations
Study Summary
Chlamydia is a common infection among youth and can be given from one person to another during sex. Many people who have chlamydia have no signs of infection at all, but can pass the infection to anyone they have sex with. If not treated, chlamydia can lead to serious health problems. This study will look at how well medicines given for chlamydia infection work. The study requires 306 evaluable subjects, chlamydia-positive, males and non-pregnant females, ages 12-21, living in long-term, gender-segregated youth correctional facilities. Participants will be assigned to receive either doxycycline (2 times per day, by mouth, for 7 days) or azithromycin (1 single dose by mouth). Study procedures will include collection of at least 3 urine samples to test for chlamydia. Study visits will occur during initial enrollment in the study, day 28 after starting treatment, and day 67. Participants will be involved in study related procedures for up to 67 days.
Conditions Studied
Interventions
- DRUG Azithromycin
- DRUG Doxycycline
Study Locations (2)
Alabama
- University of Alabama Hospital - Infectious Diseases - Birmingham
California
- Los Angeles County Department of Public Health - Sexually Transmitted Disease Program - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 567 participants |
| Start Date | 2009-12 |
| Est. Completion | 2014-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00980148
The ClinicalTrials.gov registry entry for NCT00980148 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 567 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chlamydial Infection appearing as the primary indexed condition, and to 2 interventions - of which Azithromycin is the first listed.
NCT00980148 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, California.
Frequently Asked Questions
What is clinical trial NCT00980148 about?
NCT00980148 is a clinical study titled "Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities". Chlamydia is a common infection among youth and can be given from one person to another during sex. Many people who have chlamydia have no signs of infection at all, but can pass the infection to anyone they have sex with. If not treated, chlamydia can lead to serious health problems. This study wil...
What is the current status of trial NCT00980148?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 567 participants. The study started on 2009-12. Estimated completion is 2014-05.
What conditions does trial NCT00980148 study?
This clinical trial studies the following conditions: Chlamydial Infection.
What interventions are being tested in trial NCT00980148?
The interventions under investigation include: Azithromycin (DRUG), Doxycycline (DRUG).
Who is sponsoring clinical trial NCT00980148?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00980148 being conducted?
This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chlamydial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.